BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 25681030)

  • 1. Fetal dose measurements and shielding efficiency assessment in a custom setup of (192)Ir brachytherapy for a pregnant woman with breast cancer.
    Candela-Juan C; Gimeno-Olmos J; Pujades MC; Rivard MJ; Carmona V; Lliso F; Celada F; Ramírez-Coves JL; Ballester F; Tormo A; Perez-Calatayud J
    Phys Med; 2015 May; 31(3):286-92. PubMed ID: 25681030
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Photon-beam radiotherapy in pregnant patients: can the fetal dose be limited to 10 cGy or less?
    Kourinou KM; Mazonakis M; Lyraraki E; Damilakis J
    Phys Med; 2015 Feb; 31(1):85-91. PubMed ID: 25455441
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Shielding effect of a customized intraoral mold including lead material in high-dose-rate 192-Ir brachytherapy for oral cavity cancer.
    Kudoh T; Ikushima H; Honda E
    J Radiat Res; 2012; 53(1):130-7. PubMed ID: 22223463
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HDR brachytherapy of rectal cancer using a novel grooved-shielding applicator design.
    Webster MJ; Devic S; Vuong T; Han DY; Scanderbeg D; Choi D; Song B; Song WY
    Med Phys; 2013 Sep; 40(9):091704. PubMed ID: 24007137
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fetal dose estimates for electron-beam treatment to the chest wall of a pregnant patient.
    Antolak JA; Strom EA
    Med Phys; 1998 Dec; 25(12):2388-91. PubMed ID: 9874832
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of high-dose rate prostate brachytherapy dose distributions with iridium-192, ytterbium-169, and thulium-170 sources.
    Krishnamurthy D; Weinberg V; Cunha JA; Hsu IC; Pouliot J
    Brachytherapy; 2011; 10(6):461-5. PubMed ID: 21397569
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of breast-air and breast-lung interfaces on the dose rate at the planning target volume of a MammoSite catheter for Yb-169 and Ir-192 HDR sources.
    Cazeca MJ; Medich DC; Munro JJ
    Med Phys; 2010 Aug; 37(8):4038-45. PubMed ID: 20879565
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dosimetric comparison of (192)Ir high-dose-rate brachytherapy vs. 50 kV x-rays as techniques for breast intraoperative radiation therapy: conceptual development of image-guided intraoperative brachytherapy using a multilumen balloon applicator and in-room CT imaging.
    Jones R; Libby B; Showalter SL; Brenin DR; Wilson DD; Schroen A; Morris M; Reardon KA; Morrison J; Showalter TN
    Brachytherapy; 2014; 13(5):502-7. PubMed ID: 24933339
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Accelerated partial breast irradiation: an analysis of variables associated with late toxicity and long-term cosmetic outcome after high-dose-rate interstitial brachytherapy.
    Wazer DE; Kaufman S; Cuttino L; DiPetrillo T; Arthur DW
    Int J Radiat Oncol Biol Phys; 2006 Feb; 64(2):489-95. PubMed ID: 16246495
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of finite patient dimensions and tissue inhomogeneities on dosimetry planning of 192Ir HDR breast brachytherapy: a Monte Carlo dose verification study.
    Pantelis E; Papagiannis P; Karaiskos P; Angelopoulos A; Anagnostopoulos G; Baltas D; Zamboglou N; Sakelliou L
    Int J Radiat Oncol Biol Phys; 2005 Apr; 61(5):1596-602. PubMed ID: 15817368
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [A special radiation shielding for the radiotherapy of a pregnant patient].
    Buchgeister M; Mondry A; Spillner P; Paulsen F; Belka C; Bamberg M
    Strahlenther Onkol; 2008 Feb; 184(2):80-5. PubMed ID: 18259699
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dosimetric analysis of a shielded applicator for nasopharyngeal carcinoma intracavitary brachytherapy: Monte Carlo calculation.
    Chen LX; Liu XW; You RA; Qian JY; Qi ZY; Deng XW; Tsao SY
    Med Phys; 2006 Mar; 33(3):761-9. PubMed ID: 16878578
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quality control in interstitial brachytherapy of the breast using pulsed dose rate: treatment planning and dose delivery with an Ir-192 afterloading system.
    Mangold CA; Rijnders A; Georg D; Van Limbergen E; Pötter R; Huyskens D
    Radiother Oncol; 2001 Jan; 58(1):43-51. PubMed ID: 11165681
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of a new foetal shielding device for pregnant brain tumour patients.
    Kang S; Kim KH; Kang SW; Shin DS; Lee S; Chung JB
    Radiat Oncol; 2021 Jun; 16(1):109. PubMed ID: 34120633
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acute genitourinary toxicity after high-dose-rate (HDR) brachytherapy combined with hypofractionated external-beam radiation therapy for localized prostate cancer: correlation between the urethral dose in HDR brachytherapy and the severity of acute genitourinary toxicity.
    Akimoto T; Ito K; Saitoh J; Noda SE; Harashima K; Sakurai H; Nakayama Y; Yamamoto T; Suzuki K; Nakano T; Niibe H
    Int J Radiat Oncol Biol Phys; 2005 Oct; 63(2):463-71. PubMed ID: 16168838
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of rib and lung heterogeneities on the computed dose to lung in Ir-192 high-dose-rate breast brachytherapy: Monte Carlo versus a treatment planning system.
    Yazdi HS; Shamsaei M; Jaberi R; Shabani HR; Allahverdi M; Vaezzadeh SA
    J Cancer Res Ther; 2012; 8(3):394-8. PubMed ID: 23174721
    [TBL] [Abstract][Full Text] [Related]  

  • 17. On the determination of the effective transmission factor for stainless steel ovoid shielding segments and estimation of their shielding efficacy for the clinical situation.
    Verellen D; De Neve W; Van den Heuvel F; Storme G; Coen V; Coghe M
    Med Phys; 1994 Nov; 21(11):1677-84. PubMed ID: 7891627
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Patient-specific Monte Carlo dose calculations for high-dose-rate endorectal brachytherapy with shielded intracavitary applicator.
    Poon E; Williamson JF; Vuong T; Verhaegen F
    Int J Radiat Oncol Biol Phys; 2008 Nov; 72(4):1259-66. PubMed ID: 18954720
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acute complications of MammoSite brachytherapy: a single institution's initial clinical experience.
    Harper JL; Jenrette JM; Vanek KN; Aguero EG; Gillanders WE
    Int J Radiat Oncol Biol Phys; 2005 Jan; 61(1):169-74. PubMed ID: 15629608
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Radiotherapy for supradiaphragmatic Hodgkin's disease: determination of the proper fetal shielding conditions using Monte Carlo methodology.
    Mazonakis M; Tzedakis A; Varveris C; Damilakis J
    Phys Med; 2011 Oct; 27(4):181-7. PubMed ID: 21216645
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.